Healthcare Sector Stocks
The Healthcare sector has a total of 1054 stocks, with a combined market cap of $9.01 trillion, total revenue of $4.62 trillion and a weighted average PE ratio of 43.26.
Market Cap
9.01T
Revenue
4.62T
Profits
208.24B
PE Ratio
43.26
Profit Margin
4.51%
Dividend Yield
0.40%
1054 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.02T | -0.86% | 1,668,432 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 621.71B | 0.84% | 3,138,000 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 444.53B | -2.26% | 3,426,934 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 380.15B | -0.68% | 1,688,792 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 322.48B | 0.60% | 3,252,620 | 65.77B |
| 6 | NVS | Novartis AG | 298.75B | -1.34% | 858,296 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 265.22B | -0.57% | 1,052,707 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 213.09B | -0.58% | 1,126,336 | 46.34B |
| 9 | NVO | Novo Nordisk A/S | 208.62B | -9.61% | 20,522,749 | 50.57B |
| 10 | AMGN | Amgen Inc. | 208.25B | -0.46% | 1,004,106 | 37.22B |
| 11 | ABT | Abbott Laboratories | 183.14B | 0.22% | 4,185,694 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 162.35B | -0.40% | 3,666,201 | 29.74B |
| 13 | PFE | Pfizer Inc. | 143.17B | 0.84% | 24,361,460 | 63.32B |
| 14 | DHR | Danaher Corporation | 137.94B | 0.03% | 2,122,696 | 25.11B |
| 15 | CVS | CVS Health Corporation | 134.20B | -0.04% | 2,616,622 | 405.62B |
| 16 | BMY | Bristol-Myers Squibb Company | 133.16B | 0.51% | 7,450,721 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 125.10B | 0.32% | 1,457,976 | 11.03B |
| 18 | SYK | Stryker Corporation | 124.52B | -6.67% | 2,914,779 | 25.84B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 121.03B | -1.01% | 437,198 | 12.22B |
| 20 | MDT | Medtronic plc | 109.65B | -0.06% | 3,521,870 | 36.36B |
| 21 | GSK | GSK plc | 103.86B | -0.42% | 2,325,743 | 44.05B |
| 22 | MCK | McKesson Corporation | 100.80B | -0.52% | 451,072 | 403.43B |
| 23 | SNY | Sanofi | 100.71B | -0.21% | 2,170,348 | 54.60B |
| 24 | HCA | HCA Healthcare, Inc. | 87.02B | 1.55% | 588,357 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 82.04B | 0.50% | 390,430 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 75.28B | 2.11% | 580,589 | 15.53B |
| 27 | CI | The Cigna Group | 74.70B | -1.72% | 1,071,746 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 68.77B | 0.59% | 11,205,537 | 21.00B |
| 29 | COR | Cencora, Inc. | 60.68B | -0.11% | 381,829 | 328.68B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 55.21B | -0.70% | 2,508,999 | 28.42B |
| 31 | CAH | Cardinal Health, Inc. | 53.86B | 1.28% | 746,740 | 250.74B |
| 32 | ARGX | argenx SE | 53.75B | -1.86% | 201,021 | 5.32B |
| 33 | MDLN | Medline Inc. | 51.39B | - | 1,747,973 | 29.14B |
| 34 | EW | Edwards Lifesciences Corporation | 49.68B | -0.74% | 1,836,287 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 45.56B | -0.05% | 725,702 | 22.23B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 43.94B | -0.32% | 308,228 | 4.45B |
| 37 | HUM | Humana Inc. | 43.89B | -0.31% | 695,585 | 145.68B |
| 38 | HLN | Haleon plc | 43.65B | -2.13% | 7,236,868 | 14.80B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 40.91B | -0.85% | 2,467,894 | 17.32B |
| 40 | RVMD | Revolution Medicines, Inc. | 40.21B | -1.58% | 755,203 | - |
| 41 | A | Agilent Technologies, Inc. | 39.16B | -0.03% | 785,927 | 7.23B |
| 42 | IQV | IQVIA Holdings Inc. | 38.74B | -1.03% | 624,850 | 16.98B |
| 43 | NTRA | Natera, Inc. | 38.18B | -1.14% | 879,008 | 2.50B |
| 44 | WAT | Waters Corporation | 37.02B | -0.85% | 363,209 | 3.77B |
| 45 | ONC | BeOne Medicines AG | 35.00B | -2.24% | 145,462 | 5.74B |
| 46 | ALC | Alcon Inc. | 33.93B | -1.59% | 1,589,951 | 10.63B |
| 47 | RPRX | Royalty Pharma plc | 33.76B | -0.66% | 932,409 | 2.44B |
| 48 | VEEV | Veeva Systems Inc. | 33.07B | 1.01% | 1,010,506 | 3.32B |
| 49 | ZTS | Zoetis Inc. | 32.36B | 1.54% | 2,480,030 | 9.53B |
| 50 | DXCM | DexCom, Inc. | 31.68B | 12.61% | 7,847,947 | 4.97B |
| 51 | ILMN | Illumina, Inc. | 30.83B | -0.63% | 2,886,600 | 4.49B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 30.83B | -2.42% | 2,612,271 | 21.27B |
| 53 | CNC | Centene Corporation | 30.61B | 1.86% | 1,653,857 | 180.30B |
| 54 | RMD | ResMed Inc. | 30.37B | 0.97% | 568,212 | 5.54B |
| 55 | BIIB | Biogen Inc. | 30.30B | -1.37% | 518,778 | 10.03B |
| 56 | MTD | Mettler-Toledo International Inc. | 28.39B | 1.76% | 145,215 | 4.13B |
| 57 | ALNY | Alnylam Pharmaceuticals, Inc. | 27.12B | -1.36% | 2,867,484 | 4.80B |
| 58 | DGX | Quest Diagnostics Incorporated | 25.84B | -0.09% | 435,494 | 11.56B |
| 59 | PHG | Koninklijke Philips N.V. | 25.57B | -1.10% | 852,292 | 20.18B |
| 60 | LH | Labcorp Holdings Inc. | 25.19B | -1.31% | 556,164 | 14.35B |
| 61 | INCY | Incyte Corporation | 24.35B | -2.33% | 847,138 | 5.82B |
| 62 | ROIV | Roivant Sciences Ltd. | 24.28B | -2.23% | 2,575,675 | 8.26M |
| 63 | WST | West Pharmaceutical Services, Inc. | 23.98B | 0.33% | 404,037 | 3.33B |
| 64 | BNTX | BioNTech SE | 22.95B | -2.25% | 442,099 | 3.23B |
| 65 | STE | STERIS plc | 22.30B | -1.05% | 333,222 | 5.94B |
| 66 | MRNA | Moderna, Inc. | 22.19B | -3.44% | 5,468,729 | 2.23B |
| 67 | UTHR | United Therapeutics Corporation | 22.09B | -1.03% | 199,216 | 3.17B |
| 68 | GH | Guardant Health, Inc. | 21.71B | 6.17% | 3,008,256 | 1.18B |
| 69 | INSM | Insmed Incorporated | 21.26B | -3.34% | 1,767,727 | 819.56M |
| 70 | VTRS | Viatris Inc. | 20.48B | -0.99% | 2,705,649 | 14.56B |
| 71 | THC | Tenet Healthcare Corporation | 20.39B | 0.21% | 543,273 | 21.81B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 18.15B | -1.18% | 1,670,684 | 8.41B |
| 73 | GMAB | Genmab A/S | 17.56B | 0.75% | 1,311,155 | 3.90B |
| 74 | NBIX | Neurocrine Biosciences, Inc. | 16.74B | -10.25% | 3,261,106 | 3.37B |
| 75 | ASND | Ascendis Pharma A/S | 16.16B | -2.37% | 287,858 | 998.25M |
| 76 | MEDP | Medpace Holdings, Inc. | 16.03B | -0.66% | 127,476 | 2.78B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.85B | -2.36% | 309,859 | 4.44B |
| 78 | BBIO | BridgeBio Pharma, Inc. | 15.66B | -2.48% | 1,045,365 | 579.96M |
| 79 | DVA | DaVita Inc. | 15.43B | 0.62% | 163,486 | 13.84B |
| 80 | SOLV | Solventum Corporation | 14.85B | -1.20% | 393,829 | 8.26B |
| 81 | COO | The Cooper Companies, Inc. | 14.11B | -0.43% | 1,526,987 | 4.23B |
| 82 | FMS | Fresenius Medical Care AG | 13.55B | -0.27% | 301,273 | 22.32B |
| 83 | BAX | Baxter International Inc. | 13.55B | -2.02% | 4,651,902 | 11.47B |
| 84 | SNN | Smith & Nephew plc | 13.43B | -3.08% | 1,022,004 | 6.16B |
| 85 | EXEL | Exelixis, Inc. | 13.38B | -4.90% | 1,474,825 | 2.38B |
| 86 | ELAN | Elanco Animal Health Incorporated | 13.10B | -0.85% | 2,922,469 | 4.89B |
| 87 | ICLR | ICON Public Limited Company | 12.89B | 0.91% | 495,832 | 8.29B |
| 88 | RVTY | Revvity, Inc. | 12.61B | -0.44% | 534,314 | 2.90B |
| 89 | PEN | Penumbra, Inc. | 12.60B | 0.20% | 134,489 | 1.50B |
| 90 | BTSG | BrightSpring Health Services, Inc. | 12.52B | -17.55% | 5,232,295 | 14.37B |
| 91 | CORT | Corcept Therapeutics Incorporated | 12.30B | -3.84% | 1,016,025 | 830.81M |
| 92 | ALGN | Align Technology, Inc. | 12.19B | -1.83% | 947,670 | 4.14B |
| 93 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.01B | -2.39% | 871,803 | 622.01M |
| 94 | BMRN | BioMarin Pharmaceutical Inc. | 11.62B | -0.76% | 1,347,605 | 3.24B |
| 95 | PODD | Insulet Corporation | 11.52B | 0.39% | 694,706 | 2.90B |
| 96 | AXSM | Axsome Therapeutics, Inc. | 11.27B | -6.68% | 487,306 | 708.24M |
| 97 | CRL | Charles River Laboratories International, Inc. | 11.25B | -0.45% | 214,154 | 4.03B |
| 98 | TECH | Bio-Techne Corporation | 11.24B | 0.15% | 3,209,776 | 1.21B |
| 99 | EHC | Encompass Health Corporation | 11.02B | 0.15% | 189,068 | 6.07B |
| 100 | ABVX | ABIVAX Société Anonyme | 10.77B | -1.47% | 860,037 | 5.67M |
| 101 | GMED | Globus Medical, Inc. | 10.76B | -1.26% | 471,559 | 3.10B |
| 102 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.67B | -6.13% | 545,034 | 1.28B |
| 103 | CYTK | Cytokinetics, Incorporated | 10.61B | -2.87% | 628,628 | 105.82M |
| 104 | SMMT | Summit Therapeutics Inc. | 10.56B | -1.49% | 2,111,627 | - |
| 105 | ENSG | The Ensign Group, Inc. | 10.26B | -0.77% | 161,690 | 5.49B |
| 106 | KRYS | Krystal Biotech, Inc. | 10.19B | -5.80% | 243,347 | 417.30M |
| 107 | MOH | Molina Healthcare, Inc. | 10.17B | 0.28% | 276,779 | 42.47B |
| 108 | UHS | Universal Health Services, Inc. | 10.14B | 2.62% | 677,348 | 18.11B |
| 109 | APGE | Apogee Therapeutics, Inc. | 10.07B | -0.16% | 1,170,222 | - |
| 110 | RDY | Dr. Reddy's Laboratories Limited | 10.01B | -0.42% | 1,551,314 | 3.50B |
| 111 | GKOS | Glaukos Corporation | 9.85B | -0.81% | 483,029 | 612.84M |
| 112 | HSIC | Henry Schein, Inc. | 9.80B | 1.02% | 639,688 | 13.38B |
| 113 | HALO | Halozyme Therapeutics, Inc. | 9.79B | -0.88% | 672,188 | 1.51B |
| 114 | BRKR | Bruker Corporation | 9.59B | -2.08% | 1,038,199 | 3.46B |
| 115 | OSCR | Oscar Health, Inc. | 9.47B | 0.67% | 1,622,835 | 13.30B |
| 116 | AVTR | Avantor, Inc. | 9.27B | -1.08% | 6,993,202 | 6.56B |
| 117 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.83B | 0.14% | 892,924 | 18.07M |
| 118 | PTGX | Protagonist Therapeutics, Inc. | 8.72B | -2.24% | 285,255 | 74.06M |
| 119 | BIO | Bio-Rad Laboratories, Inc. | 8.72B | -0.32% | 81,988 | 2.59B |
| 120 | SYRE | Spyre Therapeutics, Inc. | 8.63B | -3.33% | 336,465 | - |
| 121 | QGEN | Qiagen N.V. | 8.59B | 0.16% | 647,424 | 2.10B |
| 122 | IONS | Ionis Pharmaceuticals, Inc. | 8.57B | -3.27% | 1,282,594 | 874.09M |
| 123 | PRAX | Praxis Precision Medicines, Inc. | 8.55B | -0.37% | 234,494 | 7.46M |
| 124 | ATR | AptarGroup, Inc. | 8.52B | -0.28% | 423,690 | 3.93B |
| 125 | KYMR | Kymera Therapeutics, Inc. | 8.51B | -3.28% | 269,632 | 51.48M |
| 126 | HQY | HealthEquity, Inc. | 8.39B | -0.59% | 304,229 | 1.34B |
| 127 | ALKS | Alkermes plc | 8.23B | -2.00% | 809,595 | 1.67B |
| 128 | RGEN | Repligen Corporation | 8.07B | -0.41% | 358,540 | 785.10M |
| 129 | IMVT | Immunovant, Inc. | 7.93B | -2.63% | 266,730 | - |
| 130 | TEM | Tempus AI, Inc. | 7.90B | -1.15% | 5,009,504 | 1.43B |
| 131 | PCVX | Vaxcyte, Inc. | 7.86B | -2.75% | 285,076 | - |
| 132 | LQDA | Liquidia Corporation | 7.65B | -0.84% | 557,652 | 288.07M |
| 133 | IBRX | ImmunityBio, Inc. | 7.59B | -2.68% | 6,061,537 | 140.98M |
| 134 | PACS | PACS Group, Inc. | 7.42B | -0.21% | 432,968 | 5.43B |
| 135 | TGTX | TG Therapeutics, Inc. | 7.32B | -3.55% | 1,426,081 | 700.35M |
| 136 | CHE | Chemed Corporation | 7.08B | 0.14% | 131,032 | 2.60B |
| 137 | GRFS | Grifols, S.A. | 6.84B | -4.51% | 388,509 | 8.48B |
| 138 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.79B | -6.24% | 212,259 | 217.17M |
| 139 | COGT | Cogent Biosciences, Inc. | 6.70B | -5.20% | 686,393 | - |
| 140 | MIRM | Mirum Pharmaceuticals, Inc. | 6.58B | -4.21% | 226,078 | 569.61M |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.51B | -0.97% | 549,966 | 1.55B |
| 142 | HIMS | Hims & Hers Health, Inc. | 6.41B | 2.46% | 9,153,219 | 2.37B |
| 143 | BLLN | BillionToOne, Inc. | 6.34B | -1.21% | 252,693 | 354.54M |
| 144 | ERAS | Erasca, Inc. | 6.27B | -3.37% | 1,332,835 | - |
| 145 | CGON | CG Oncology, Inc. | 6.25B | -3.04% | 262,612 | 5.07M |
| 146 | BLTE | Belite Bio, Inc | 6.22B | -1.19% | 111,013 | - |
| 147 | XENE | Xenon Pharmaceuticals Inc. | 6.10B | -1.62% | 360,794 | 7.50M |
| 148 | TXG | 10x Genomics, Inc. | 6.06B | -3.36% | 1,467,270 | 638.78M |
| 149 | BLCO | Bausch + Lomb Corporation | 5.98B | -1.38% | 204,566 | 5.32B |
| 150 | TFX | Teleflex Incorporated | 5.88B | 0.47% | 193,241 | 2.13B |
| 151 | HNGE | Hinge Health, Inc. | 5.85B | 0.61% | 488,738 | 646.34M |
| 152 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.83B | -4.46% | 687,891 | 840.85M |
| 153 | DNTH | Dianthus Therapeutics, Inc. | 5.83B | -5.38% | 433,579 | 1.34M |
| 154 | DFTX | Definium Therapeutics, Inc. | 5.81B | -1.60% | 1,057,500 | - |
| 155 | AMRX | Amneal Pharmaceuticals, Inc. | 5.81B | -1.62% | 1,070,689 | 3.12B |
| 156 | ORKA | Oruka Therapeutics, Inc. | 5.77B | -2.19% | 460,943 | - |
| 157 | LGND | Ligand Pharmaceuticals Incorporated | 5.77B | -1.70% | 130,096 | 274.48M |
| 158 | SRRK | Scholar Rock Holding Corporation | 5.68B | -3.33% | 440,805 | - |
| 159 | TWST | Twist Bioscience Corporation | 5.63B | -0.96% | 722,848 | 409.48M |
| 160 | PTCT | PTC Therapeutics, Inc. | 5.63B | -10.73% | 2,990,879 | 1.01B |
| 161 | STVN | Stevanato Group S.p.A. | 5.44B | -1.29% | 111,621 | 1.39B |
| 162 | TVTX | Travere Therapeutics, Inc. | 5.20B | -2.32% | 794,566 | 536.20M |
| 163 | MMSI | Merit Medical Systems, Inc. | 5.11B | 2.72% | 1,580,195 | 1.58B |
| 164 | SHC | Sotera Health Company | 5.10B | 0.17% | 593,456 | 1.19B |
| 165 | MMED | MiniMed Group, Inc. | 5.05B | -0.91% | 342,273 | 3.10B |
| 166 | RDNT | RadNet, Inc. | 5.03B | 2.06% | 269,959 | 2.14B |
| 167 | INDV | Indivior Pharmaceuticals, Inc. | 4.82B | -1.77% | 512,485 | 1.29B |
| 168 | CRSP | CRISPR Therapeutics AG | 4.73B | -0.85% | 653,632 | 4.10M |
| 169 | DYN | Dyne Therapeutics, Inc. | 4.64B | -3.26% | 940,792 | - |
| 170 | MANE | Veradermics, Incorporated | 4.48B | 2.60% | 451,248 | - |
| 171 | NVST | Envista Holdings Corporation | 4.46B | -1.40% | 1,530,204 | 2.81B |
| 172 | LIVN | LivaNova PLC | 4.44B | -0.20% | 251,897 | 1.43B |
| 173 | ACAD | ACADIA Pharmaceuticals Inc. | 4.41B | -3.01% | 832,833 | 1.10B |
| 174 | CAI | Caris Life Sciences, Inc. | 4.40B | -3.17% | 1,783,698 | 907.29M |
| 175 | PBLS | Parabilis Medicines, Inc. | 4.24B | 3.16% | 220,112 | - |
| 176 | ICUI | ICU Medical, Inc. | 4.24B | 0.65% | 148,743 | 2.16B |
| 177 | CELC | Celcuity Inc. | 4.23B | -1.01% | 330,518 | - |
| 178 | EWTX | Edgewise Therapeutics, Inc. | 4.16B | -5.86% | 513,328 | - |
| 179 | RLAY | Relay Therapeutics, Inc. | 4.13B | -2.62% | 964,613 | 10.68M |
| 180 | LFST | LifeStance Health Group, Inc. | 4.12B | -1.02% | 1,071,878 | 1.49B |
| 181 | WAY | Waystar Holding Corp. | 4.08B | 1.72% | 2,361,514 | 1.21B |
| 182 | CON | Concentra Group Holdings Parent, Inc. | 4.04B | -0.03% | 252,416 | 2.23B |
| 183 | TNGX | Tango Therapeutics, Inc. | 3.92B | -1.60% | 899,751 | 56.99M |
| 184 | IRTC | iRhythm Holdings, Inc. | 3.88B | -0.75% | 241,524 | 787.85M |
| 185 | ELVN | Enliven Therapeutics, Inc. | 3.85B | 2.16% | 349,064 | - |
| 186 | HAE | Haemonetics Corporation | 3.82B | -0.85% | 396,946 | 1.33B |
| 187 | DOCS | Doximity, Inc. | 3.77B | -1.27% | 1,157,834 | 644.86M |
| 188 | VCYT | Veracyte, Inc. | 3.73B | -21.75% | 3,853,336 | 561.90M |
| 189 | VKTX | Viking Therapeutics, Inc. | 3.72B | -3.23% | 1,035,127 | - |
| 190 | DNLI | Denali Therapeutics Inc. | 3.71B | -4.07% | 611,901 | - |
| 191 | ADPT | Adaptive Biotechnologies Corporation | 3.64B | -5.33% | 1,559,639 | 308.08M |
| 192 | ALMS | Alumis Inc. | 3.58B | -2.97% | 851,488 | 8.40M |
| 193 | LEGN | Legend Biotech Corporation | 3.58B | -2.89% | 1,717,460 | 1.14B |
| 194 | OGN | Organon & Co. | 3.56B | 0.04% | 675,972 | 6.13B |
| 195 | RCUS | Arcus Biosciences, Inc. | 3.55B | -0.18% | 728,578 | 236.00M |
| 196 | NHC | National HealthCare Corporation | 3.53B | -1.21% | 60,909 | 1.53B |
| 197 | BKD | Brookdale Senior Living Inc. | 3.47B | -0.48% | 1,153,653 | 3.00B |
| 198 | ITGR | Integer Holdings Corporation | 3.44B | 0.47% | 147,386 | 1.86B |
| 199 | OPCH | Option Care Health, Inc. | 3.43B | 2.05% | 1,803,920 | 5.69B |
| 200 | GPCR | Structure Therapeutics Inc. | 3.40B | -3.43% | 206,385 | - |
| 201 | TLX | Telix Pharmaceuticals Limited | 3.39B | -1.29% | 61,261 | 803.79M |
| 202 | IDYA | IDEAYA Biosciences, Inc. | 3.39B | -2.09% | 194,851 | 225.27M |
| 203 | ARQT | Arcutis Biotherapeutics, Inc. | 3.34B | -4.66% | 670,296 | 415.62M |
| 204 | WRBY | Warby Parker Inc. | 3.27B | 2.46% | 567,891 | 890.57M |
| 205 | ALHC | Alignment Healthcare, Inc. | 3.26B | -15.15% | 10,500,628 | 4.58B |
| 206 | NAMS | NewAmsterdam Pharma Company N.V. | 3.24B | -2.57% | 550,723 | 22.57M |
| 207 | MBX | MBX Biosciences, Inc. | 3.16B | -0.02% | 402,975 | - |
| 208 | QURE | uniQure N.V. | 3.01B | 2.97% | 985,027 | 18.67M |
| 209 | PRVA | Privia Health Group, Inc. | 2.98B | -0.75% | 527,321 | 2.25B |
| 210 | RGC | Regencell Bioscience Holdings Limited | 2.96B | 0.65% | 123,236 | - |
| 211 | GRAL | GRAIL, Inc. | 2.95B | -3.33% | 241,951 | 156.12M |
| 212 | IRON | Disc Medicine, Inc. | 2.95B | -2.49% | 203,954 | - |
| 213 | CLDX | Celldex Therapeutics, Inc. | 2.93B | -3.03% | 388,790 | 865.00K |
| 214 | ACHC | Acadia Healthcare Company, Inc. | 2.75B | 5.01% | 1,203,557 | 3.37B |
| 215 | ESTA | Establishment Labs Holdings Inc. | 2.75B | -0.19% | 142,999 | 229.58M |
| 216 | XRAY | DENTSPLY SIRONA Inc. | 2.69B | -2.15% | 1,955,022 | 3.68B |
| 217 | ATAI | AtaiBeckley Inc. | 2.66B | 0.14% | 6,368,178 | 3.49M |
| 218 | TMDX | TransMedics Group, Inc. | 2.62B | -0.28% | 252,767 | 635.89M |
| 219 | NEOG | Neogen Corporation | 2.61B | 4.08% | 2,012,097 | 870.40M |
| 220 | TRVI | Trevi Therapeutics, Inc. | 2.60B | -0.33% | 690,009 | - |
| 221 | KOD | Kodiak Sciences Inc. | 2.60B | -2.12% | 257,738 | - |
| 222 | IMNM | Immunome, Inc. | 2.59B | -0.91% | 353,023 | 4.02M |
| 223 | SUPN | Supernus Pharmaceuticals, Inc. | 2.59B | -2.21% | 229,199 | 776.83M |
| 224 | BHC | Bausch Health Companies Inc. | 2.57B | 14.10% | 13,355,749 | 10.85B |
| 225 | BEAM | Beam Therapeutics Inc. | 2.55B | -3.21% | 607,584 | 164.01M |
| 226 | GRDN | Guardian Pharmacy Services, Inc. | 2.54B | -2.73% | 204,153 | 1.46B |
| 227 | TARS | Tarsus Pharmaceuticals, Inc. | 2.52B | -1.80% | 248,424 | 535.08M |
| 228 | PLSE | Pulse Biosciences, Inc. | 2.46B | 1.47% | 140,341 | 751.00K |
| 229 | RARE | Ultragenyx Pharmaceutical Inc. | 2.45B | -4.22% | 588,711 | 670.00M |
| 230 | PGNY | Progyny, Inc. | 2.44B | -0.92% | 403,946 | 1.29B |
| 231 | NRIX | Nurix Therapeutics, Inc. | 2.41B | -1.36% | 383,632 | 36.77M |
| 232 | NKTR | Nektar Therapeutics | 2.40B | -0.59% | 241,843 | 55.63M |
| 233 | PBH | Prestige Consumer Healthcare Inc. | 2.37B | 0.14% | 175,395 | 1.09B |
| 234 | VCEL | Vericel Corporation | 2.35B | -3.57% | 243,084 | 306.30M |
| 235 | LMAT | LeMaitre Vascular, Inc. | 2.32B | -0.51% | 115,878 | 256.28M |
| 236 | VERA | Vera Therapeutics, Inc. | 2.30B | -3.06% | 854,956 | - |
| 237 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.28B | -2.76% | 1,454,821 | 885.72M |
| 238 | PHVS | Pharvaris N.V. | 2.28B | -3.81% | 311,222 | - |
| 239 | MLYS | Mineralys Therapeutics, Inc. | 2.25B | -2.48% | 309,065 | - |
| 240 | AXGN | Axogen, Inc. | 2.25B | 1.20% | 619,168 | 251.17M |
| 241 | CLOV | Clover Health Investments, Corp. | 2.24B | -1.84% | 1,618,389 | 2.21B |
| 242 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.23B | -3.37% | 918,235 | -665.00K |
| 243 | CDNA | CareDx, Inc. | 2.22B | 13.03% | 1,577,802 | 458.09M |
| 244 | NUVB | Nuvation Bio Inc. | 2.21B | -5.30% | 2,419,971 | 143.05M |
| 245 | KLRA | Kailera Therapeutics, Inc. | 2.20B | -0.56% | 210,902 | - |
| 246 | HTFL | HeartFlow, Inc. | 2.20B | -1.43% | 315,973 | 191.42M |
| 247 | COAG | Hemab Therapeutics Holdings, Inc. | 2.19B | -1.12% | 319,337 | - |
| 248 | PGEN | Precigen, Inc. | 2.16B | 2.19% | 3,407,295 | 31.60M |
| 249 | SION | Sionna Therapeutics, Inc. | 2.13B | 0.94% | 250,332 | - |
| 250 | ADUS | Addus HomeCare Corporation | 2.12B | -0.59% | 65,560 | 1.45B |
| 251 | MD | Pediatrix Medical Group, Inc. | 2.11B | -0.49% | 179,656 | 1.93B |
| 252 | VRDN | Viridian Therapeutics, Inc. | 2.10B | -4.40% | 557,758 | 70.92M |
| 253 | ZLAB | Zai Lab Limited | 2.05B | 0.25% | 213,226 | 453.28M |
| 254 | AVAH | Aveanna Healthcare Holdings Inc. | 2.04B | -3.30% | 972,800 | 2.52B |
| 255 | PVLA | Palvella Therapeutics, Inc. | 2.03B | -5.64% | 91,359 | - |
| 256 | BHVN | Biohaven Ltd. | 2.03B | -2.53% | 760,542 | - |
| 257 | HRMY | Harmony Biosciences Holdings, Inc. | 2.02B | -2.77% | 246,455 | 899.11M |
| 258 | NEO | NeoGenomics, Inc. | 2.02B | -1.20% | 1,972,585 | 766.30M |
| 259 | SGRY | Surgery Partners, Inc. | 2.00B | -2.70% | 614,423 | 3.34B |
| 260 | ZBIO | Zenas BioPharma, Inc. | 1.99B | -2.51% | 237,306 | 10.00M |
| 261 | WGS | GeneDx Holdings Corp. | 1.98B | -3.13% | 408,941 | 442.68M |
| 262 | RAPP | Rapport Therapeutics, Inc. | 1.98B | -3.27% | 111,784 | 20.00M |
| 263 | NBTX | Nanobiotix S.A. | 1.98B | -4.20% | 105,008 | 38.27M |
| 264 | UFPT | UFP Technologies, Inc. | 1.98B | 0.18% | 66,990 | 608.85M |
| 265 | SLS | SELLAS Life Sciences Group, Inc. | 1.97B | -2.72% | 3,346,936 | - |
| 266 | HCM | HUTCHMED (China) Limited | 1.96B | 3.16% | 26,756 | 549.12M |
| 267 | ADMA | ADMA Biologics, Inc. | 1.96B | -2.65% | 665,129 | 509.86M |
| 268 | GHRS | GH Research PLC | 1.93B | -0.67% | 82,485 | - |
| 269 | ATRC | AtriCure, Inc. | 1.93B | -5.68% | 707,860 | 569.62M |
| 270 | AUPH | Aurinia Pharmaceuticals Inc. | 1.93B | -0.20% | 1,063,189 | 298.30M |
| 271 | BFLY | Butterfly Network, Inc. | 1.91B | -12.12% | 6,309,436 | 112.14M |
| 272 | TYRA | Tyra Biosciences, Inc. | 1.90B | -3.45% | 434,568 | - |
| 273 | URGN | UroGen Pharma Ltd. | 1.88B | -5.94% | 393,227 | 140.49M |
| 274 | SNDA | Sonida Senior Living, Inc. | 1.88B | 0.29% | 187,621 | 367.34M |
| 275 | FBRX | Forte Biosciences, Inc. | 1.87B | -0.47% | 566,590 | - |
| 276 | MESO | Mesoblast Limited | 1.87B | -2.54% | 123,472 | 65.38M |
| 277 | TSHA | Taysha Gene Therapies, Inc. | 1.87B | -0.68% | 970,786 | 7.47M |
| 278 | AGIO | Agios Pharmaceuticals, Inc. | 1.85B | -4.89% | 879,889 | 98.34M |
| 279 | KARD | Kardigan, Inc. | 1.85B | 1.22% | 207,717 | - |
| 280 | LKFT | Lakefront Biotherapeutics NV | 1.83B | -1.12% | 100,999 | 1.20B |
| 281 | IOVA | Iovance Biotherapeutics, Inc. | 1.83B | -12.79% | 15,007,211 | 285.61M |
| 282 | OCUL | Ocular Therapeutix, Inc. | 1.82B | -2.07% | 1,191,843 | 52.04M |
| 283 | FTRE | Fortrea Holdings Inc. | 1.81B | -0.03% | 996,823 | 2.68B |
| 284 | STOK | Stoke Therapeutics, Inc. | 1.80B | -3.66% | 479,579 | 32.08M |
| 285 | GENB | Generate Biomedicines, Inc. | 1.80B | 0.21% | 211,357 | 30.30M |
| 286 | DMRA | Damora Therapeutics, Inc. | 1.78B | -0.86% | 179,496 | - |
| 287 | NVCR | NovoCure Limited | 1.77B | -0.13% | 633,767 | 699.19M |
| 288 | ALMR | Alamar Biosciences, Inc. | 1.74B | 0.28% | 56,985 | 87.16M |
| 289 | BCAX | Bicara Therapeutics Inc. | 1.72B | -0.08% | 361,484 | - |
| 290 | IMCR | Immunocore Holdings plc | 1.71B | -0.65% | 454,562 | 412.81M |
| 291 | ABCL | AbCellera Biologics Inc. | 1.71B | -1.76% | 3,298,263 | 79.21M |
| 292 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.70B | -2.30% | 574,229 | 204.73M |
| 293 | ANIP | ANI Pharmaceuticals, Inc. | 1.67B | -1.80% | 115,945 | 923.71M |
| 294 | ENOV | Enovis Corporation | 1.67B | -0.82% | 285,042 | 2.28B |
| 295 | SNDX | Syndax Pharmaceuticals, Inc. | 1.67B | -3.18% | 566,816 | 217.17M |
| 296 | TRLV | Trulieve Cannabis Corp. | 1.64B | -0.70% | 460,177 | 1.17B |
| 297 | OMCL | Omnicell, Inc. | 1.62B | -4.28% | 553,137 | 1.25B |
| 298 | ASTH | Astrana Health, Inc. | 1.61B | -2.56% | 278,219 | 3.53B |
| 299 | SRPT | Sarepta Therapeutics, Inc. | 1.60B | -2.51% | 1,761,133 | 2.18B |
| 300 | HCSG | Healthcare Services Group, Inc. | 1.59B | 0.39% | 193,101 | 1.86B |
| 301 | RXRX | Recursion Pharmaceuticals, Inc. | 1.59B | -1.64% | 9,707,483 | 66.41M |
| 302 | AAPG | Ascentage Pharma Group International | 1.59B | -2.82% | 3,547 | 82.08M |
| 303 | TRAX | First Tracks Biotherapeutics, Inc. | 1.58B | -5.10% | 381,470 | - |
| 304 | ZYME | Zymeworks Inc. | 1.57B | -3.48% | 155,077 | 81.26M |
| 305 | AGL | agilon health, inc. | 1.57B | -2.81% | 82,400 | 5.82B |
| 306 | ANAB | AnaptysBio, Inc. | 1.56B | -4.00% | 193,256 | 232.39M |
| 307 | INNV | InnovAge Holding Corp. | 1.56B | -1.12% | 153,390 | 949.17M |
| 308 | SEPN | Septerna, Inc. | 1.55B | -1.96% | 113,674 | 72.26M |
| 309 | INVA | Innoviva, Inc. | 1.55B | -0.94% | 236,695 | 420.69M |
| 310 | BLFS | BioLife Solutions, Inc. | 1.54B | -0.51% | 380,724 | 101.66M |
| 311 | CMPS | COMPASS Pathways plc | 1.53B | -2.03% | 1,437,479 | - |
| 312 | MLTX | MoonLake Immunotherapeutics | 1.53B | -2.79% | 439,292 | - |
| 313 | ARDT | Ardent Health, Inc. | 1.52B | -1.30% | 161,473 | 6.43B |
| 314 | NTLA | Intellia Therapeutics, Inc. | 1.50B | -3.34% | 1,570,047 | 66.09M |
| 315 | XNCR | Xencor, Inc. | 1.49B | -6.33% | 469,288 | 97.36M |
| 316 | MAZE | Maze Therapeutics, Inc. | 1.49B | -2.66% | 155,581 | 20.00M |
| 317 | ATEC | Alphatec Holdings, Inc. | 1.47B | -0.88% | 979,919 | 787.08M |
| 318 | XERS | Xeris Biopharma Holdings, Inc. | 1.47B | -3.86% | 858,089 | 314.85M |
| 319 | PAHC | Phibro Animal Health Corporation | 1.47B | -0.91% | 91,984 | 1.50B |
| 320 | VIR | Vir Biotechnology, Inc. | 1.46B | -3.03% | 517,002 | 65.50M |
| 321 | INSP | Inspire Medical Systems, Inc. | 1.45B | 0.46% | 329,933 | 915.25M |
| 322 | HROW | Harrow, Inc. | 1.43B | -1.36% | 119,919 | 268.68M |
| 323 | AHCO | AdaptHealth Corp. | 1.42B | -0.09% | 297,433 | 3.29B |
| 324 | AVBP | ArriVent BioPharma, Inc. | 1.41B | -1.40% | 199,254 | - |
| 325 | ALVO | Alvotech | 1.41B | 10.36% | 1,006,702 | 562.04M |
| 326 | PRGO | Perrigo Company plc | 1.40B | -1.55% | 1,280,069 | 4.18B |
| 327 | PNTG | The Pennant Group, Inc. | 1.40B | -1.85% | 109,992 | 1.02B |
| 328 | SVRA | Savara Inc. | 1.38B | -2.08% | 543,311 | - |
| 329 | CNMD | CONMED Corporation | 1.37B | -2.85% | 267,513 | 1.37B |
| 330 | GLUE | Monte Rosa Therapeutics, Inc. | 1.34B | -29.89% | 5,223,142 | 42.95M |
| 331 | KMTS | Kestra Medical Technologies, Ltd. | 1.33B | -1.77% | 155,690 | 95.13M |
| 332 | TNDM | Tandem Diabetes Care, Inc. | 1.33B | 1.84% | 1,034,093 | 1.03B |
| 333 | ABSI | Absci Corporation | 1.32B | 1.70% | 1,358,253 | 1.84M |
| 334 | AMN | AMN Healthcare Services, Inc. | 1.32B | -2.28% | 283,302 | 3.42B |
| 335 | PSNL | Personalis, Inc. | 1.31B | 2.20% | 1,796,265 | 64.52M |
| 336 | AHG | Akso Health Group | 1.31B | -3.77% | 1,444 | 13.83M |
| 337 | AORT | Artivion, Inc. | 1.30B | -2.89% | 276,815 | 458.69M |
| 338 | AZTA | Azenta, Inc. | 1.30B | -2.22% | 206,839 | 596.48M |
| 339 | IART | Integra LifeSciences Holdings Corporation | 1.29B | -3.27% | 400,523 | 1.65B |
| 340 | AVLN | Avalyn Pharma Inc. | 1.27B | -2.22% | 73,499 | - |
| 341 | ETON | Eton Pharmaceuticals, Inc. | 1.27B | -5.71% | 272,921 | 86.93M |
| 342 | CERT | Certara, Inc. | 1.26B | 3.73% | 2,698,797 | 419.75M |
| 343 | MNKD | MannKind Corporation | 1.25B | -4.99% | 3,800,026 | 360.78M |
| 344 | TDOC | Teladoc Health, Inc. | 1.24B | 3.50% | 5,468,803 | 2.49B |
| 345 | FRNM | Freenome, Inc. | 1.23B | 9.31% | 927,979 | 34.24M |
| 346 | AKTS | Aktis Oncology, Inc. | 1.23B | -3.26% | 180,895 | 8.28M |
| 347 | ARDX | Ardelyx, Inc. | 1.23B | -1.49% | 1,484,304 | 427.68M |
| 348 | USPH | U.S. Physical Therapy, Inc. | 1.22B | -0.11% | 308,083 | 787.69M |
| 349 | INBX | Inhibrx Biosciences, Inc. | 1.22B | -2.22% | 61,678 | 1.30M |
| 350 | STAA | STAAR Surgical Company | 1.21B | 0.21% | 776,304 | 290.38M |
| 351 | NVAX | Novavax, Inc. | 1.20B | -1.75% | 2,048,666 | 596.34M |
| 352 | IMTX | Immatics N.V. | 1.19B | -5.33% | 107,337 | 43.00M |
| 353 | IRMD | IRADIMED CORPORATION | 1.19B | -2.51% | 241,615 | 86.34M |
| 354 | JBIO | Jade Biosciences, Inc. | 1.18B | -0.43% | 311,013 | - |
| 355 | OMDA | Omada Health, Inc. | 1.18B | 0.51% | 587,408 | 283.30M |
| 356 | ORIC | ORIC Pharmaceuticals, Inc. | 1.16B | -4.12% | 582,176 | - |
| 357 | QDEL | QuidelOrtho Corporation | 1.14B | 1.33% | 243,153 | 2.66B |
| 358 | COLL | Collegium Pharmaceutical, Inc. | 1.14B | -1.97% | 121,481 | 796.33M |
| 359 | VOR | Vor Biopharma Inc. | 1.14B | -3.90% | 497,988 | - |
| 360 | LBRX | LB Pharmaceuticals Inc | 1.13B | -3.91% | 148,413 | - |
| 361 | SDGR | Schrödinger, Inc. | 1.12B | -2.61% | 724,789 | 254.91M |
| 362 | CRVS | Corvus Pharmaceuticals, Inc. | 1.11B | 0.30% | 336,288 | - |
| 363 | MGTX | MeiraGTx Holdings plc | 1.10B | -0.83% | 250,660 | 79.76M |
| 364 | WVE | Wave Life Sciences Ltd. | 1.10B | -3.21% | 1,617,799 | 65.37M |
| 365 | BVS | Bioventus Inc. | 1.10B | -0.46% | 440,118 | 576.30M |
| 366 | CRON | Cronos Group Inc. | 1.08B | -2.25% | 598,194 | 159.54M |
| 367 | SPTX | Seaport Therapeutics, Inc. | 1.07B | -1.43% | 53,709 | - |
| 368 | DRTS | Alpha Tau Medical Ltd. | 1.07B | -0.42% | 178,795 | - |
| 369 | ANRO | Alto Neuroscience, Inc. | 1.06B | -4.80% | 167,625 | - |
| 370 | PRCT | PROCEPT BioRobotics Corporation | 1.04B | 1.50% | 534,526 | 322.02M |
| 371 | GDRX | GoodRx Holdings, Inc. | 1.04B | -3.15% | 366,233 | 787.89M |
| 372 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | -0.43% | 1,225,156 | 69.64M |
| 373 | PCRX | Pacira BioSciences, Inc. | 1.03B | -2.67% | 209,086 | 734.86M |
| 374 | IVA | Inventiva S.A. | 1.03B | -3.46% | 794,323 | 7.94M |
| 375 | NUTX | Nutex Health Inc. | 1.02B | -0.22% | 132,697 | 879.95M |
| 376 | EYPT | EyePoint, Inc. | 1.02B | -5.37% | 834,767 | 7.61M |
| 377 | OLMA | Olema Pharmaceuticals, Inc. | 1.01B | -1.78% | 347,745 | - |
| 378 | CGEM | Cullinan Therapeutics, Inc. | 1.01B | -5.82% | 413,704 | - |
| 379 | GMRS | GMR Solutions Inc. | 1.01B | 3.31% | 88,441 | 5.83B |
| 380 | OPK | OPKO Health, Inc. | 1.00B | 0.37% | 1,618,241 | 587.90M |
| 381 | LMRI | Lumexa Imaging Holdings, Inc. | 990.59M | 0.59% | 133,184 | 1.03B |
| 382 | AVTX | Avalo Therapeutics, Inc. | 990.34M | -3.46% | 393,673 | 59.00K |
| 383 | SANA | Sana Biotechnology, Inc. | 941.68M | -3.38% | 1,403,146 | - |
| 384 | JANX | Janux Therapeutics, Inc. | 922.39M | -2.92% | 188,391 | 13.73M |
| 385 | REPL | Replimune Group, Inc. | 917.73M | 102.03% | 26,912,336 | - |
| 386 | CSTL | Castle Biosciences, Inc. | 899.28M | 10.68% | 575,083 | 357.28M |
| 387 | ODTX | Odyssey Therapeutics, Inc. | 896.76M | 1.68% | 91,583 | 1.06M |
| 388 | APMD | Apnimed, Inc. | 875.99M | 36.87% | 2,349,414 | 120.15M |
| 389 | TBPH | Theravance Biopharma, Inc. | 874.34M | 0.12% | 184,420 | 109.78M |
| 390 | TALK | Talkspace, Inc. | 873.58M | 0.10% | 1,152,372 | 238.37M |
| 391 | AMPH | Amphastar Pharmaceuticals, Inc. | 871.72M | -2.99% | 174,192 | 720.53M |
| 392 | INMD | InMode Ltd. | 871.70M | 0.46% | 175,206 | 374.64M |
| 393 | OMER | Omeros Corporation | 857.65M | -0.67% | 588,228 | 9.89M |
| 394 | ABUS | Arbutus Biopharma Corporation | 846.45M | -2.83% | 573,204 | 191.45M |
| 395 | ANNX | Annexon, Inc. | 833.96M | -3.42% | 1,659,607 | - |
| 396 | HSTM | HealthStream, Inc. | 814.81M | -1.10% | 70,064 | 311.78M |
| 397 | GLAS | Glass House Brands Inc. | 814.17M | -3.33% | 211,361 | 177.68M |
| 398 | DBVT | DBV Technologies S.A. | 812.86M | -2.24% | 232,091 | 5.04M |
| 399 | SLDB | Solid Biosciences Inc. | 806.30M | -3.53% | 438,190 | - |
| 400 | KURA | Kura Oncology, Inc. | 795.42M | -3.76% | 662,733 | 71.64M |
| 401 | GERN | Geron Corporation | 792.28M | -7.84% | 13,389,647 | 196.12M |
| 402 | SIBN | SI-BONE, Inc. | 790.75M | -0.89% | 171,879 | 206.22M |
| 403 | SSII | SS Innovations International, Inc. | 786.52M | -1.50% | 29,205 | 48.47M |
| 404 | AURA | Aura Biosciences, Inc. | 772.65M | -1.48% | 163,204 | - |
| 405 | AVR | Anteris Technologies Global Corp. | 766.97M | -4.49% | 434,981 | 1.85M |
| 406 | DSGN | Design Therapeutics, Inc. | 765.10M | -2.93% | 371,909 | - |
| 407 | MNPR | Monopar Therapeutics Inc. | 746.31M | -2.83% | 382,460 | - |
| 408 | TENX | Tenax Therapeutics, Inc. | 745.43M | -3.38% | 739,457 | - |
| 409 | SGP | SpyGlass Pharma, Inc. | 741.38M | -2.40% | 43,748 | - |
| 410 | CADL | Candel Therapeutics, Inc. | 739.30M | 2.23% | 691,496 | - |
| 411 | DRUG | Bright Minds Biosciences Inc. | 731.41M | -1.51% | 180,906 | - |
| 412 | ACRS | Aclaris Therapeutics, Inc. | 719.27M | -3.20% | 649,671 | 8.37M |
| 413 | FTH | Faeth Therapeutics, Inc. | 713.30M | -3.99% | 180,662 | - |
| 414 | PHAR | Pharming Group N.V. | 712.11M | -7.07% | 22,003 | 366.48M |
| 415 | EVO | Evotec SE | 706.41M | - | 18,934 | 859.03M |
| 416 | PHAT | Phathom Pharmaceuticals, Inc. | 703.75M | -1.88% | 1,532,176 | 239.66M |
| 417 | IRWD | Ironwood Pharmaceuticals, Inc. | 701.25M | 14.21% | 2,567,339 | 361.51M |
| 418 | CLYM | Climb Bio, Inc. | 694.86M | 0.46% | 375,892 | - |
| 419 | NVCT | Nuvectis Pharma, Inc. | 685.37M | -4.48% | 98,845 | - |
| 420 | RIGL | Rigel Pharmaceuticals, Inc. | 682.91M | -3.02% | 79,666 | 299.77M |
| 421 | CTMX | CytomX Therapeutics, Inc. | 682.50M | -4.42% | 2,405,416 | 35.54M |
| 422 | OCS | Oculis Holding AG | 679.37M | 0.36% | 126,008 | 1.40M |
| 423 | PHR | Phreesia, Inc. | 665.40M | 1.46% | 294,864 | 495.59M |
| 424 | CBLL | CeriBell, Inc. | 663.62M | -0.85% | 189,247 | 95.07M |
| 425 | ALLO | Allogene Therapeutics, Inc. | 659.25M | -3.05% | 3,827,417 | 22.00K |
| 426 | NGNE | Neurogene Inc. | 657.19M | -1.85% | 79,765 | 925.00K |
| 427 | ACHV | Achieve Life Sciences, Inc. | 650.86M | 0.63% | 559,137 | - |
| 428 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 649.67M | -4.59% | 163,735 | - |
| 429 | GYRE | Gyre Therapeutics, Inc. | 639.95M | -1.20% | 19,496 | 117.05M |
| 430 | TCMD | Tactile Systems Technology, Inc. | 633.61M | -0.39% | 68,596 | 343.52M |
| 431 | AGMB | AgomAb Therapeutics NV | 631.36M | 0.51% | 51,131 | - |
| 432 | BWAY | BrainsWay Ltd. | 617.46M | 0.07% | 63,262 | 56.22M |
| 433 | TLRY | Tilray Brands, Inc. | 612.30M | 7.50% | 4,535,116 | 915.45M |
| 434 | MDXG | MiMedx Group, Inc. | 612.17M | -3.75% | 1,591,804 | 355.17M |
| 435 | MPLT | MapLight Therapeutics, Inc. | 612.17M | -3.78% | 726,564 | - |
| 436 | ANGO | AngioDynamics, Inc. | 606.76M | -0.61% | 234,422 | 320.17M |
| 437 | RGNX | REGENXBIO Inc. | 603.45M | -3.36% | 636,844 | 87.82M |
| 438 | BBNX | Beta Bionics, Inc. | 598.81M | -6.73% | 1,314,942 | 119.01M |
| 439 | IMMX | Immix Biopharma, Inc. | 597.28M | -1.87% | 1,055,242 | - |
| 440 | CBIO | Crescent Biopharma, Inc. | 592.58M | -4.53% | 178,600 | 11.88M |
| 441 | CRMD | CorMedix Inc. | 586.04M | -0.27% | 299,202 | 400.05M |
| 442 | ZVRA | Zevra Therapeutics, Inc. | 571.64M | 0.31% | 596,510 | 122.29M |
| 443 | CTNM | Contineum Therapeutics, Inc. | 564.91M | -4.06% | 291,690 | - |
| 444 | STTK | Shattuck Labs, Inc. | 551.33M | - | 442,308 | 1.00M |
| 445 | RLMD | Relmada Therapeutics, Inc. | 551.20M | -1.78% | 540,312 | - |
| 446 | ALT | Altimmune, Inc. | 549.39M | -5.20% | 2,593,188 | 36.00K |
| 447 | CTKB | Cytek Biosciences, Inc. | 546.92M | -1.74% | 306,512 | 204.17M |
| 448 | FDMT | 4D Molecular Therapeutics, Inc. | 542.10M | 2.98% | 383,410 | 88.24M |
| 449 | PRME | Prime Medicine, Inc. | 533.72M | -2.15% | 1,089,317 | 4.03M |
| 450 | DNA | Ginkgo Bioworks Holdings, Inc. | 527.82M | -0.12% | 344,384 | 151.40M |
| 451 | TECX | Tectonic Therapeutic, Inc. | 525.22M | -2.37% | 73,062 | - |
| 452 | SLN | Silence Therapeutics plc | 524.77M | -4.39% | 199,824 | 839.00K |
| 453 | WEAV | Weave Communications, Inc. | 523.14M | 0.23% | 290,862 | 248.72M |
| 454 | SPRY | ARS Pharmaceuticals, Inc. | 518.36M | -7.28% | 1,214,771 | 98.99M |
| 455 | ARVN | Arvinas, Inc. | 516.81M | -3.49% | 351,072 | 89.40M |
| 456 | KIDS | OrthoPediatrics Corp. | 516.78M | 0.05% | 53,798 | 243.30M |
| 457 | ANL | Adlai Nortye Ltd. | 514.00M | -1.15% | 81,277 | 5.00M |
| 458 | ZURA | Zura Bio Limited | 512.04M | -2.71% | 270,098 | - |
| 459 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 460 | EIKN | Eikon Therapeutics, Inc. | 494.88M | -4.98% | 131,446 | - |
| 461 | TOI | The Oncology Institute, Inc. | 492.81M | -2.78% | 605,630 | 545.76M |
| 462 | FLGT | Fulgent Genetics, Inc. | 492.18M | -14.25% | 828,178 | 323.93M |
| 463 | VSTM | Verastem, Inc. | 489.90M | -8.61% | 800,382 | 49.59M |
| 464 | ARTV | Artiva Biotherapeutics, Inc. | 489.77M | -3.36% | 249,061 | 251.00K |
| 465 | RZLT | Rezolute, Inc. | 488.90M | -4.10% | 477,985 | - |
| 466 | ASMB | Assembly Biosciences, Inc. | 486.86M | -2.95% | 56,548 | 71.10M |
| 467 | HELP | Cybin Inc. | 484.41M | -3.99% | 476,955 | - |
| 468 | SOPH | SOPHiA GENETICS SA | 475.27M | -1.65% | 43,399 | 81.18M |
| 469 | PRLD | Prelude Therapeutics Incorporated | 475.06M | -5.15% | 154,443 | 16.72M |
| 470 | OFIX | Orthofix Medical Inc. | 473.74M | -0.59% | 105,807 | 825.37M |
| 471 | VREX | Varex Imaging Corporation | 471.62M | 1.08% | 155,289 | 857.50M |
| 472 | SI | Shoulder Innovations, Inc. | 469.10M | -2.46% | 33,589 | 53.89M |
| 473 | VALN | Valneva SE | 468.61M | -1.30% | 11,943 | 180.25M |
| 474 | QTTB | Q32 Bio Inc. | 468.19M | 1.09% | 243,877 | 53.74M |
| 475 | PROK | ProKidney Corp. | 466.68M | -2.22% | 648,310 | 889.00K |
| 476 | AQST | Aquestive Therapeutics, Inc. | 462.97M | -0.81% | 1,137,068 | 50.27M |
| 477 | VMD | Viemed Healthcare, Inc. | 447.77M | -0.68% | 343,603 | 286.57M |
| 478 | KYTX | Kyverna Therapeutics, Inc. | 447.45M | -1.74% | 344,052 | - |
| 479 | CLPT | ClearPoint Neuro, Inc. | 447.44M | 2.33% | 421,716 | 40.61M |
| 480 | PACB | Pacific Biosciences of California, Inc. | 441.05M | -4.05% | 1,915,565 | 160.03M |
| 481 | NPCE | NeuroPace, Inc. | 439.81M | -6.18% | 141,117 | 99.53M |
| 482 | SGMT | Sagimet Biosciences Inc. | 439.67M | -2.60% | 236,925 | - |
| 483 | NRC | NRC Health | 439.47M | 4.97% | 109,115 | 140.00M |
| 484 | BIOA | BioAge Labs, Inc. | 435.19M | -60.60% | 7,691,069 | 10.32M |
| 485 | NNNN | Anbio Biotechnology | 434.96M | -7.81% | 9,002 | 8.65M |
| 486 | SLBT | SL Science Holding Limited | 434.77M | - | 11,705 | 3.36M |
| 487 | CERS | Cerus Corporation | 433.28M | -25.61% | 6,654,490 | 221.55M |
| 488 | CABA | Cabaletta Bio, Inc. | 432.91M | -2.39% | 1,175,593 | - |
| 489 | SRTA | Strata Critical Medical, Inc. | 431.77M | -1.96% | 520,036 | 228.58M |
| 490 | PRTA | Prothena Corporation plc | 426.68M | -3.09% | 253,688 | 57.94M |
| 491 | IKT | Inhibikase Therapeutics, Inc. | 426.02M | -4.39% | 217,598 | 1.00 |
| 492 | EPRX | Eupraxia Pharmaceuticals Inc. | 424.26M | -2.06% | 358,016 | - |
| 493 | OVID | Ovid Therapeutics Inc. | 419.94M | -5.06% | 959,440 | 7.12M |
| 494 | OCGN | Ocugen, Inc. | 419.77M | -1.59% | 2,228,090 | 4.47M |
| 495 | KMDA | Kamada Ltd. | 418.44M | 1.55% | 41,311 | 181.68M |
| 496 | DCTH | Delcath Systems, Inc. | 416.68M | 0.25% | 186,073 | 90.44M |
| 497 | STRO | Sutro Biopharma, Inc. | 405.98M | -1.29% | 80,434 | 99.61M |
| 498 | AUTL | Autolus Therapeutics plc | 405.87M | -0.33% | 556,933 | 92.62M |
| 499 | EVMN | Evommune, Inc. | 403.77M | -1.23% | 140,695 | 10.00M |
| 500 | BNTC | Benitec Biopharma Inc. | 402.98M | -1.10% | 70,887 | - |